Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00934518
Recruitment Status : Terminated (Inadequate patient accrual)
First Posted : July 8, 2009
Last Update Posted : July 29, 2010
Information provided by:
Penn State University

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : July 2016
  Study Completion Date : No date given